About Alcentra Capital (NASDAQ:ABDC)
Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million. Its investments range in size from $5 million to $15 million. Its investment objective is to generate both current income and capital appreciation primarily by making direct investments in lower middle-market companies in the form of senior debt, unitranche, second lien, subordinated debt and, to a lesser extent, senior debt and minority equity investments. Its investment focus is to make loans to, and selected equity investments in, privately-held lower-middle-market companies.
Industry, Sector and Symbol
Trailing P/E Ratio-5.28888888888889
Forward P/E Ratio7.60
Sales & Book Value
Annual Sales$33.35 million
Price / Sales3.04
Cash Flow$1.47 per share
Price / Cash4.87
Book Value$11.07 per share
Price / Book0.64
Return on Equity10.56%
Return on Assets6.19%
Alcentra Capital (NASDAQ:ABDC) Frequently Asked Questions
What is Alcentra Capital's stock symbol?
Alcentra Capital trades on the NASDAQ under the ticker symbol "ABDC."
How often does Alcentra Capital pay dividends? What is the dividend yield for Alcentra Capital?
Alcentra Capital announced a quarterly dividend on Thursday, March 15th. Shareholders of record on Friday, March 30th will be paid a dividend of $0.18 per share on Wednesday, April 4th. This represents a $0.72 annualized dividend and a yield of 10.08%. The ex-dividend date of this dividend is Wednesday, March 28th. View Alcentra Capital's Dividend History.
How will Alcentra Capital's stock buyback program work?
Alcentra Capital announced that its board has authorized a share repurchase program on Friday, November 17th 2017, which authorizes the company to repurchase $2,500,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares repurchase programs are generally an indication that the company's management believes its stock is undervalued.
How were Alcentra Capital's earnings last quarter?
Alcentra Capital Corp (NASDAQ:ABDC) announced its earnings results on Monday, November, 6th. The asset manager reported $0.34 EPS for the quarter, beating the Zacks' consensus estimate of $0.33 by $0.01. The asset manager had revenue of $7.61 million for the quarter. Alcentra Capital had a positive return on equity of 10.56% and a negative net margin of 57.28%. View Alcentra Capital's Earnings History.
When will Alcentra Capital make its next earnings announcement?
Where is Alcentra Capital's stock going? Where will Alcentra Capital's stock price be in 2018?
4 brokerages have issued 1 year price targets for Alcentra Capital's shares. Their predictions range from $7.00 to $15.00. On average, they expect Alcentra Capital's stock price to reach $12.00 in the next year. View Analyst Ratings for Alcentra Capital.
Who are some of Alcentra Capital's key competitors?
Some companies that are related to Alcentra Capital include MVC Capital (MVC), Stellus Capital Investment (SCM), OFS Capital (OFS), StoneCastle Financial (BANX), Garrison Capital (GARS), Saratoga Investment (SAR), Capitala Finance (CPTA), Medallion Financial (MFIN), Horizon Technology Finance (HRZN), KCAP Financial (KCAP), CM Finance (CMFN), Consumer Portfolio Services (CPSS), Emergent Capital (EMGC), Manhattan Bridge Capital (LOAN) and Marathon Patent Group (MARA).
Who are Alcentra Capital's key executives?
Alcentra Capital's management team includes the folowing people:
- Paul M.A. Hatfield, Chairman of the Board
- David Scopelliti, President, Chief Executive Officer, Director (Age 52)
- Ellida McMillan, Chief Financial Officer, Chief Operating Officer, Chief Accounting Officer, Treasurer, Secretary (Age 49)
- Branko Krmpotic, Executive Vice President
- Steven Reiff, Lead Independent Director
- T. Ulrich Brechbuhl, Director
- Douglas J. Greenlaw, Director
- Rudolph L. Hertlein, Director
Has Alcentra Capital been receiving favorable news coverage?
News headlines about ABDC stock have trended somewhat positive this week, Accern Sentiment reports. Accern rates the sentiment of news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Alcentra Capital earned a news sentiment score of 0.19 on Accern's scale. They also assigned news stories about the asset manager an impact score of 45.50 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
Who are Alcentra Capital's major shareholders?
Alcentra Capital's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Stilwell Value LLC (7.28%),
(7.20%), Bank of New York Mellon Corp (4.26%), Muzinich & Co. Inc. (4.05%), Confluence Investment Management LLC (1.53%) and Raymond James & Associates (1.03%). Company insiders that own Alcentra Capital stock include Branko Krmpotic, David Scopelliti, Douglas J /Ma Greenlaw, Ellida Mcmillan, Of New York Mellon Corp Bank, Paul J Echausse, Steven H Reiff and T Ulrich Brechbuhl. View Institutional Ownership Trends for Alcentra Capital.
Which institutional investors are selling Alcentra Capital stock?
ABDC stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Raymond James Financial Services Advisors Inc., Raymond James & Associates, Muzinich & Co. Inc. and Confluence Investment Management LLC. Company insiders that have sold Alcentra Capital company stock in the last year include Of New York Mellon Corp Bank and Paul J Echausse. View Insider Buying and Selling for Alcentra Capital.
Which institutional investors are buying Alcentra Capital stock?
ABDC stock was bought by a variety of institutional investors in the last quarter, including Stilwell Value LLC, Pacific Ridge Capital Partners LLC, Bramshill Investments LLC, Caxton Corp, Wasatch Advisors Inc., Portland Investment Counsel Inc. and BlackRock Inc.. Company insiders that have bought Alcentra Capital stock in the last two years include Branko Krmpotic, David Scopelliti, Douglas J /Ma Greenlaw, Ellida Mcmillan, Paul J Echausse, Steven H Reiff and T Ulrich Brechbuhl. View Insider Buying and Selling for Alcentra Capital.
How do I buy shares of Alcentra Capital?
Shares of ABDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Alcentra Capital's stock price today?
One share of ABDC stock can currently be purchased for approximately $7.14.
How big of a company is Alcentra Capital?
Alcentra Capital has a market capitalization of $95.75 million and generates $33.35 million in revenue each year. The asset manager earns $-19,100,000.00 in net income (profit) each year or ($1.35) on an earnings per share basis.
How can I contact Alcentra Capital?
Alcentra Capital's mailing address is 200 PARK AVENUE 7TH FLOOR, NEW YORK NY, 10166. The asset manager can be reached via phone at 212-922-8240 or via email at [email protected]
MarketBeat Community Rating for Alcentra Capital (ABDC)MarketBeat's community ratings are surveys of what our community members think about Alcentra Capital and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Alcentra Capital (NASDAQ:ABDC) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Hold||Hold||Hold||Hold|
|Consensus Rating Score: ||2.00||2.00||1.75||2.40|
|Ratings Breakdown: ||1 Sell Rating(s)|
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
|1 Sell Rating(s)|
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
|2 Sell Rating(s)|
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$12.00||$12.83||$12.83||$13.50|
|Price Target Upside: ||68.07% upside||52.96% upside||74.60% upside||18.73% upside|
Alcentra Capital (NASDAQ:ABDC) Consensus Price Target History
Alcentra Capital (NASDAQ:ABDC) Analyst Ratings History
(Data available from 3/24/2016 forward)
Alcentra Capital (NASDAQ:ABDC) Earnings History and Estimates Chart
Alcentra Capital (NASDAQ ABDC) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/3/2018|| || || || || || || || |
|11/6/2017||Q3 2017||$0.33||$0.34||$7.61 million||View||N/A|
|8/3/2017||Q2 2017||$0.36||$0.36||$9.38 million||$8.34 million||View||N/A|
|5/4/2017||Q1 2017||$0.36||$0.34||$9.23 million||$9.20 million||View||N/A|
|3/9/2017||Q4 2016||$0.35||$0.45||$9.52 million||$10.90 million||View||Listen|
|11/3/2016||Q316||$0.35||$0.35||$9.15 million||$9.12 million||View||N/A|
|8/4/2016||Q216||$0.36||$0.44||$9.09 million||$10.64 million||View||N/A|
|5/5/2016||Q116||$0.36||$0.41||$8.96 million||$9.95 million||View||N/A|
|3/9/2016||Q415||$0.35||$0.34||$8.91 million||$8.68 million||View||N/A|
|11/9/2015||Q3 2015||$0.37||$0.38||$8.97 million||$8.51 million||View||N/A|
|8/11/2015||Q215||$0.34||$0.34||$8.14 million||$8.51 million||View||Listen|
|5/12/2015||Q1||$0.35||$0.37||$7.89 million||$8.23 million||View||Listen|
|3/18/2015||Q4 2014||$0.34||$0.34||$6.54 million||$6.67 million||View||N/A|
|11/10/2014||Q3 2014||$0.33||$0.34||$6.01 million||$5.86 million||View||N/A|
Alcentra Capital (NASDAQ:ABDC) Earnings Estimates
2018 EPS Consensus Estimate: $1.31
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Alcentra Capital (NASDAQ:ABDC) Dividend Information
|Payout Ratio:||-74.07% (Trailing 12 Months of Earnings) |
106.38% (Based on This Year's Estimates)
112.36% (Based on Next Year's Estimates)
Alcentra Capital (NASDAQ:ABDC) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Alcentra Capital (NASDAQ ABDC) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 4.96%
Institutional Ownership Percentage: 35.01%
Alcentra Capital (NASDAQ ABDC) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|3/23/2018||Douglas J /Ma Greenlaw||Director||Buy||1,000||$7.15||$7,150.00||1,000|| |
|3/20/2018||Branko Krmpotic||Insider||Buy||10,000||$6.15||$61,500.00||14,000|| |
|3/20/2018||David Scopelliti||CEO||Buy||3,000||$6.18||$18,540.00||9,100|| |
|3/20/2018||Ellida Mcmillan||CFO||Buy||750||$6.13||$4,597.50||2,600|| |
|11/15/2017||David Scopelliti||CEO||Buy||1,500||$7.10||$10,650.00||6,100|| |
|11/15/2017||Ellida Mcmillan||CFO||Buy||130||$7.10||$923.00||1,850|| |
|11/15/2017||T Ulrich Brechbuhl||Director||Buy||3,200||$7.03||$22,496.00||6,800|| |
|11/13/2017||Steven H Reiff||Director||Buy||6,900||$7.23||$49,887.00||35,246|| |
|11/9/2017||Paul J Echausse||Director||Sell||10,000||$7.45||$74,500.00||58,946|| |
|8/8/2017||Ellida Mcmillan||CFO||Buy||250||$10.58||$2,645.00||1,720|| |
|8/7/2017||Steven H Reiff||Director||Buy||11,668||$10.72||$125,080.96||7,000|| |
|5/22/2017||Of New York Mellon Corp Bank||Major Shareholder||Sell||1,691,839||$13.13||$22,213,846.07|| |
|12/2/2016||Paul J Echausse||CEO||Buy||1,800||$11.49||$20,682.00||68,946|| |
|9/8/2016||David Scopelliti||Insider||Buy||2,000||$12.88||$25,760.00||4,600|| |
|6/23/2016||Ellida Mcmillan||CAO||Buy||480||$12.18||$5,846.40||1,470|| |
|5/20/2016||Paul J Echausse||CEO||Buy||1,200||$11.89||$14,268.00||67,146|| |
|3/24/2016||David Scopelliti||SVP||Buy||500||$11.27||$5,635.00||2,600|| |
|3/24/2016||Ellida Mcmillan||CAO||Buy||790||$11.29||$8,919.10||990|| |
|3/24/2016||Paul J Echausse||CEO||Buy||800||$11.45||$9,160.00||65,946|| |
|3/22/2016||Paul J Echausse||CEO||Buy||800||$11.29||$9,032.00||65,146|| |
|3/18/2016||David Scopelliti||SVP||Buy||500||$10.76||$5,380.00||2,100|| |
|3/17/2016||David Scopelliti||SVP||Buy||2,550||$12.77||$32,563.50||1,600|| |
|3/17/2016||Paul J Echausse||CEO||Buy||800||$10.84||$8,672.00||64,346|| |
|3/15/2016||Paul J Echausse||CEO||Buy||800||$10.90||$8,720.00||63,546|| |
|9/24/2015||Alcentra Investments Ltd||major shareholder||Sell||1,475,620||$12.89||$19,020,741.80|| |
|8/14/2015||Rudolph L Hertlein||Director||Buy||1,400||$12.88||$18,032.00|| |
|6/23/2015||David Scopelliti||SVP||Buy||1,800||$13.56||$24,408.00|| |
|5/7/2015||Of New York Mellon Corp Bank||Major Shareholder||Buy||5,875||$13.69||$80,428.75|| |
|5/5/2015||Of New York Mellon Corp Bank||Major Shareholder||Buy||6,288||$13.78||$86,648.64|| |
|4/29/2015||Of New York Mellon Corp Bank||Major Shareholder||Buy||10,600||$13.78||$146,068.00|| |
|4/27/2015||Of New York Mellon Corp Bank||Major Shareholder||Buy||13,248||$13.84||$183,352.32|| |
|4/23/2015||Of New York Mellon Corp Bank||Major Shareholder||Buy||11,908||$13.80||$164,330.40|| |
|4/21/2015||Of New York Mellon Corp Bank||Major Shareholder||Buy||9,175||$13.91||$127,624.25|| |
|4/17/2015||Of New York Mellon Corp Bank||Major Shareholder||Buy||11,994||$13.89||$166,596.66|| |
|4/15/2015||Of New York Mellon Corp Bank||Major Shareholder||Buy||8,900||$13.86||$123,354.00|| |
|4/13/2015||Of New York Mellon Corp Bank||Major Shareholder||Buy||20,124||$14.15||$284,754.60|| |
|4/9/2015||Of New York Mellon Corp Bank||Major Shareholder||Buy||20,676||$14.09||$291,324.84|| |
|4/7/2015||Of New York Mellon Corp Bank||Major Shareholder||Buy||15,938||$13.58||$216,438.04|| |
|4/2/2015||Of New York Mellon Corp Bank||Major Shareholder||Buy||4,000||$13.55||$54,200.00|| |
|4/1/2015||Of New York Mellon Corp Bank||Major Shareholder||Buy||13,406||$13.63||$182,723.78|| |
|3/30/2015||Of New York Mellon Corp Bank||Major Shareholder||Buy||11,718||$13.35||$156,435.30|| |
|3/26/2015||Of New York Mellon Corp Bank||Major Shareholder||Buy||16,426||$13.84||$227,335.84|| |
|3/24/2015||Of New York Mellon Corp Bank||Major Shareholder||Buy||16,426||$14.13||$232,099.38|| |
|3/23/2015||Paul J Echausse||CEO||Buy||1,000||$14.13||$14,130.00|| |
|8/28/2014||Paul J Echausse||CEO||Buy||1,000||$13.58||$13,580.00|| |
|5/30/2014||Paul J Echausse||CEO||Buy||1,000||$14.89||$14,890.00|| |
|5/9/2014||Rudolph L Hertlein||Director||Buy||3,600||$15.00||$54,000.00|| |
Alcentra Capital (NASDAQ ABDC) News Headlines
Alcentra Capital (NASDAQ:ABDC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Alcentra Capital (NASDAQ:ABDC) Income Statement, Balance Sheet and Cash Flow Statement
Alcentra Capital (NASDAQ ABDC) Stock Chart for Saturday, March, 24, 2018